ATE256468T1 - Behandlung von nicht-entzündlichen darmerkrankungen - Google Patents

Behandlung von nicht-entzündlichen darmerkrankungen

Info

Publication number: ATE256468T1
Authority: AT; Austria
Prior art keywords: treatment; inflammatory bowel; bowel diseases; medicine; acid derivative
Prior art date: 1990-10-22

Application number

AT91918144T

Other languages

English (en)

Inventor

Thomas Julius Borody

Original Assignee

Gastro Services Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-22

Filing date

1991-10-17

Publication date

2004-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3775026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE256468(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-10-17 Application filed by Gastro Services Pty Ltd filed Critical Gastro Services Pty Ltd

2004-01-15 Application granted granted Critical

2004-01-15 Publication of ATE256468T1 publication Critical patent/ATE256468T1/de

Links

208000022559 Inflammatory bowel disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
150000003872 salicylic acid derivatives Chemical class 0.000 abstract 2
CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 abstract 1
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 abstract 1
206010010774 Constipation Diseases 0.000 abstract 1
208000012258 Diverticular disease Diseases 0.000 abstract 1
206010013554 Diverticulum Diseases 0.000 abstract 1
UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 abstract 1
206010030216 Oesophagitis Diseases 0.000 abstract 1
229960004909 aminosalicylic acid Drugs 0.000 abstract 1
201000006549 dyspepsia Diseases 0.000 abstract 1
208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000002458 infectious effect Effects 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 abstract 1
229960004963 mesalazine Drugs 0.000 abstract 1
NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 abstract 1
229960001940 sulfasalazine Drugs 0.000 abstract 1
NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT91918144T 1990-10-22 1991-10-17 Behandlung von nicht-entzündlichen darmerkrankungen ATE256468T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPK295090		1990-10-22
PCT/AU1991/000482 WO1992006690A1 (en)	1990-10-22	1991-10-17	Treatment of non-inflammatory and non-infectious bowel disorders

Publications (1)

Publication Number	Publication Date
ATE256468T1 true ATE256468T1 (de)	2004-01-15

Family

ID=3775026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91918144T ATE256468T1 (de)	1990-10-22	1991-10-17	Behandlung von nicht-entzündlichen darmerkrankungen

Country Status (7)

Country	Link
EP (1)	EP0554291B2 (de)
JP (1)	JP3425441B2 (de)
AT (1)	ATE256468T1 (de)
CA (1)	CA2090220C (de)
DE (1)	DE69133348T3 (de)
ES (1)	ES2213139T5 (de)
WO (1)	WO1992006690A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE256468T1 (de) †	1990-10-22	2004-01-15	Gastro Services Pty Ltd	Behandlung von nicht-entzündlichen darmerkrankungen
AUPO665397A0 (en) *	1997-05-07	1997-05-29	Borody, Thomas Julius	Novel therapy for constipation
US6326364B1 (en)	1999-02-08	2001-12-04	Cedars-Sinai Medical Center	Use of 5-aminosalicylates as antimicrobial agents
AUPS088702A0 (en)	2002-03-04	2002-03-28	Borody, Thomas Julius	Electrolyte purgative
CA2555304C (en) *	2004-02-06	2016-06-28	Nicolas Peter Shortis	Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
MX2011008354A (es) *	2009-02-11	2011-09-06	Cedars Sinai Medical Center	Terapia antibiotica para reducir la probabilidad de desarrollar el sindrome del intestino irritable post-infeccioso.
EP2396652B1 (de)	2009-02-11	2017-12-13	Cedars-Sinai Medical Center	Diagnose chronisch entzündlicher darmerkrankungen mittels cytolethal distending toxin
CA2752623C (en)	2009-02-16	2017-07-04	Giuliani International Limited	Alkylamido compounds and uses thereof
CA2788558C (en)	2010-02-01	2015-11-24	Mikrobex, Inc.	Bacteriotherapy for clostridium difficile colitis
DK2651415T3 (da)	2010-12-13	2020-11-30	Rite Prep Pty Ltd	Mave- og tyktarmsformuleringer og fremgangsmåder til fremstilling og brug af dem
EP2811993B1 (de)	2012-02-09	2019-10-09	Nogra Pharma Limited	Methoden zur behandlung von fibrosis
IN2014DN08157A (de)	2012-04-18	2015-05-01	Nogra Pharma Ltd
CN108175773A (zh)	2012-07-27	2018-06-19	红山生物医药有限公司	用于结肠排空的制剂和制备制剂方法
MX383428B (es)	2012-09-17	2025-03-13	Cedars Sinai Medical Center	Determinaciòn de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia.
US9511099B2 (en)	2013-06-05	2016-12-06	Rebiotix, Inc.	Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en)	2013-06-05	2017-10-10	Rebiotix, Inc.	Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en)	2013-06-05	2017-07-04	Rebiotix, Inc.	Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en)	2013-06-05	2019-08-20	Rebiotix, Inc.	Microbiota restoration therapy (MRT), compositions and methods of manufacture
WO2014197562A1 (en)	2013-06-05	2014-12-11	Rebiotix, Inc.	Microbiota restoration therapy (mrt), compositions and methods of manufacture
US9511100B2 (en)	2013-06-05	2016-12-06	Rebiotix, Inc.	Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10799539B2 (en)	2015-06-09	2020-10-13	Rebiotix, Inc.	Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en)	2015-06-09	2021-02-02	Rebiotix, Inc.	Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en)	2015-06-09	2020-11-10	Rebiotix, Inc.	Microbiota restoration therapy (MRT) compositions and methods of manufacture
AU2016274757B2 (en)	2015-06-09	2019-02-07	Ferring Microbiome Inc.	Microbiota restoration therapy (MRT) compositions and methods of manufacture
WO2018140869A1 (en)	2017-01-30	2018-08-02	Cedars-Sinai Medical Center	Diagnosis of scleroderma
CN113825739B (zh)	2019-02-08	2025-03-28	诺格拉制药有限公司	制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2021409B (en)	1977-05-25	1982-09-22	Fisons Ltd	Pharmaceutical composition
WO1981002671A1 (en) *	1980-03-20	1981-10-01	Ferring Farma Lab	Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
WO1981002672A1 (en) *	1980-03-20	1981-10-01	Ferring Farma Lab	Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease
US4664256A (en) *	1983-09-06	1987-05-12	Farmaceutisk Laboratorium Ferring A/S	Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
GB8909559D0 (en) *	1989-04-26	1989-06-14	Smith Kline French Lab	Pharmaceutical compositions
ATE256468T1 (de) †	1990-10-22	2004-01-15	Gastro Services Pty Ltd	Behandlung von nicht-entzündlichen darmerkrankungen

1991
- 1991-10-17 AT AT91918144T patent/ATE256468T1/de not_active IP Right Cessation
- 1991-10-17 EP EP91918144A patent/EP0554291B2/de not_active Expired - Lifetime
- 1991-10-17 ES ES91918144T patent/ES2213139T5/es not_active Expired - Lifetime
- 1991-10-17 JP JP51632091A patent/JP3425441B2/ja not_active Expired - Lifetime
- 1991-10-17 DE DE69133348T patent/DE69133348T3/de not_active Expired - Lifetime
- 1991-10-17 CA CA002090220A patent/CA2090220C/en not_active Expired - Lifetime
- 1991-10-17 WO PCT/AU1991/000482 patent/WO1992006690A1/en not_active Ceased

Also Published As

Publication number	Publication date
ES2213139T3 (es)	2004-08-16
DE69133348T3 (de)	2011-05-12
DE69133348T2 (de)	2004-09-16
CA2090220A1 (en)	1992-04-23
CA2090220C (en)	2003-07-08
EP0554291A4 (en)	1993-09-08
EP0554291A1 (de)	1993-08-11
ES2213139T5 (es)	2011-03-18
WO1992006690A1 (en)	1992-04-30
EP0554291B1 (de)	2003-12-17
EP0554291B2 (de)	2010-10-20
JPH06501937A (ja)	1994-03-03
JP3425441B2 (ja)	2003-07-14
DE69133348D1 (de)	2004-01-29

Similar Documents

Publication	Publication Date	Title
ATE256468T1 (de)	2004-01-15	Behandlung von nicht-entzündlichen darmerkrankungen
SE8402549L (sv)	1984-05-11	Substituerade moranolinderivat
RU94027569A (ru)	1996-03-10	Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
TNSN91070A1 (fr)	1992-10-25	Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
GR3023638T3 (en)	1997-08-29	Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
DE59102210D1 (de)	1994-08-25	Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
FR2680507B1 (fr)	1993-10-08	Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
MX9203629A (es)	1992-07-01	Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
DE69500673D1 (de)	1997-10-16	Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
FR2663328B1 (fr)	1994-08-05	Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
SE8701375D0 (sv)	1987-04-02	Novel pyridyl- and pyrimidyl derivatives
ES2153842T3 (es)	2001-03-16	Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
MX9300205A (es)	1994-07-29	Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
MX9300203A (es)	1994-07-29	Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
NO970573D0 (no)	1997-02-07	Ylidenforbindelser og deres fremstilling
DE3380923D1 (de)	1990-01-11	Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
IT1210935B (it)	1989-09-29	Composizione farmaceutica per il trattamento di malattie cardiovascolari.
NO883986D0 (no)	1988-09-07	Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
DE3762854D1 (de)	1990-06-28	Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
FR2673105B1 (fr)	1995-01-13	Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
DE69025967D1 (de)	1996-04-25	Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen
RU96104214A (ru)	1998-06-10	Способ лечения транссудативных форм центральных хориоретинальных дистрофий
IT8322949A0 (it)	1983-09-21	Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
DK0950053T3 (da)	2003-09-29	Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
PT75925A (fr)	1983-01-01	Procede de preparation de derives de diaza-3,7a cyclohepta <j,k>fluorenes et de compositions pharmaceutiques les contenant

Legal Events

Date	Code	Title	Description
2004-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties